Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
ZIO 101 in Advanced Hepatocellular Carcinoma
NCT00423306Phase 2Terminated
- Sponsor
- Alaunos Therapeutics
- Start
- May 2007
- Primary completion
- Aug 2008
- Countries
- 1
01
Overview
A Phase 2 trial of darinaparsin in hepatocellular carcinoma (HCC), sponsored by Alaunos Therapeutics. Started May 2007; status: terminated.
02
Drugs
darinaparsin
03
Conditions
hepatocellular carcinoma (HCC)
Beyond the preview
Go deeper on NCT00423306.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00423306.